Behzad Rowshanravan

1.8k citations
9 papers · 1.1k indexed · 1 hit paper · h-index 7

Behzad Rowshanravan

9 papers receiving 1.1k citations

Hit Papers

CTLA-4: a moving target in immunotherapy8762017202620202023250500750

Peers

Behzad Rowshanravan
Comparison fields: 5 of 83
  • Immunology 647
  • Oncology 612
  • Cancer Research 85
  • Pulmonary and Respiratory Medicine 166
  • Rehabilitation 29
Replace Jason B. Muhitch with:
Jason B. Muhitch United States
Takumi Maruhashi Japan
Talitha de Ruiter Netherlands
Noemi Bender Germany
Renske Goedemans Netherlands
Tristan Courau France
Genny Del Zotto Italy
Maite Álvarez United States
Sabine Huenecke Germany
Peggy J. de Vos van Steenwijk Netherlands
Behzad Rowshanravan relative to Jason B. Muhitch United States Jason B. Muhitch's profile →
Citations per field
00.5×1.5×1.9×
Jason B. Muhitch · 1×
Citations per year

Countries citing papers authored by Behzad Rowshanravan

Since Specialization
Citations

This map shows the geographic impact of Behzad Rowshanravan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Behzad Rowshanravan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Behzad Rowshanravan more than expected).

Fields of papers citing papers by Behzad Rowshanravan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Behzad Rowshanravan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Behzad Rowshanravan. The network helps show where Behzad Rowshanravan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Behzad Rowshanravan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Behzad Rowshanravan Line = papers co-authored together Behzad Rowshanravan links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1 202127
2 202126
3 202058
4 201837
5 201771
6
CTLA-4: a moving target in immunotherapybreakdown →
2017876
7 201442
8 20141
9 20094

About Behzad Rowshanravan

Behzad Rowshanravan is a scholar working on Rehabilitation, Immunology and Cell Biology, having authored 9 papers that have together received 1.1k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (6 papers), Immune Cell Function and Interaction (5 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Wound Healing and Treatments (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cellular transport and secretion (1 paper), Retinal Development and Disorders (1 paper) and Biocrusts and Microbial Ecology (1 paper). The work is most often cited by research in Immunology (647 citations), Oncology (612 citations) and Cancer Research (85 citations). Behzad Rowshanravan has collaborated with scholars based in United Kingdom, Canada and Germany. Frequent co-authors include David M. Sansom, Neil Halliday, Alan Kennedy, Tie Zheng Hou, Daniel Janman, Lucy S. K. Walker, Blagoje Soskic, Erin Waters, Cayman Williams and Claudia Hinze. Their work appears in journals such as Blood, Journal of Cell Science and Biophysical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026